Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 211-220 of 304 for heart disease

Edit search filters
  1. Contrast-Enhanced MR Angiography Method in Comparison to Current Methods in Healthy Volunteers

    Rochester, MN

  2. Non-Invasive Monitoring of Potassium Levels in Patients with Congestive Heart Failure

    Rochester, MN

  3. A Study of After Exercise Mechanical Dyssynchrony and Acute Response to Cardiac Resynchronization Therapy in Patients with Congestive Heart Failure

    Rochester, MN

  4. A Study of Long-Term Outcomes of Cardiac Resynchronization Therapy Recipients with Congestive Heart Failure

    Rochester, MN

  5. A Study to Evaluate the Disease Development and Impact of Intravascular Volume Expansion Profiles in Relation to Neuroendocrine and Renal Function in Post-Acute Heart Failure

    Rochester, MN

  6. Genotype-Phenotype Correlation in Cardiovascular Disease

    Rochester, MN

  7. A Study to See if MPI SPECT Phase Analysis Can Detect Varying Levels of Changes in Heart Rhythm Patterns

    Rochester, MN

  8. Routine Hemodynamic Monitoring following Percutaneous Coronary Interventions

    Rochester, MN

  9. Chronic Obstructive Pulmonary Disease (COPD) in Patients Hospitalized for Acute Decompensated Heart Failure

    Rochester, MN

  10. Is Our Microbiome a Predictor of Cardiac Risk

    Rochester, MN

.

Mayo Clinic Footer